Related references
Note: Only part of the references are listed.The Use of a Non-Conventional Long-Lived Gallium Radioisotope 66Ga Improves Imaging Contrast of EGFR Expression in Malignant Tumours Using DFO-ZEGFR:2377 Affibody Molecule
Maryam Oroujeni et al.
PHARMACEUTICS (2021)
A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy
Eric J. Hsu et al.
NATURE COMMUNICATIONS (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology
Karen A. Autio et al.
CLINICAL CANCER RESEARCH (2020)
Antibody prodrugs for cancer
W. Michael Kavanaugh
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Protease-activated prodrugs: strategies, challenges, and future directions
Marcin Poreba
FEBS JOURNAL (2020)
Autotransporter-Mediated Display of a Naive Affibody Library on the Outer Membrane of Escherichia coli
Ken G. Andersson et al.
BIOTECHNOLOGY JOURNAL (2019)
A coiled-coil masking domain for selective activation of therapeutic antibodies
Vivian H. Trang et al.
NATURE BIOTECHNOLOGY (2019)
Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
Dominik Summer et al.
MOLECULAR PHARMACEUTICS (2018)
Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
Mario E. Lacouture et al.
CLINICAL COLORECTAL CANCER (2018)
Affibody Molecules in Biotechnological and Medical Applications
Stefan Stahl et al.
TRENDS IN BIOTECHNOLOGY (2017)
Staphylococcus carnosus: from starter culture to protein engineering platform
John Lofblom et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
In vivo imaging of protease activity by Probody therapeutic activation
Kenneth R. Wong et al.
BIOCHIMIE (2016)
A new prodrug form of Affibody molecules (pro-Affibody) is selectively activated by cancer-associated proteases
Lisa Sandersjoo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
A protease substrate profiling method that links site-specific proteolysis with antibiotic resistance
Lisa Sandersjoo et al.
BIOTECHNOLOGY JOURNAL (2014)
Correction: Inhibiting HER3-Mediated Tumor Cell Growth with Affibody Molecules Engineered to Low Picomolar Affinity by Position-Directed Error-Prone PCR-Like Diversification
Magdalena Malm et al.
PLoS One (2013)
Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
Luc R. Desnoyers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Bacterial display in combinatorial protein engineering
John Lofblom
BIOTECHNOLOGY JOURNAL (2011)
Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand
Helena Wallberg et al.
PROTEIN EXPRESSION AND PURIFICATION (2011)
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule
Mikaela Friedman et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry
Nina Kronqvist et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Engineering of a femtomolar affinity binding protein to human serum albumin
Andreas Jonsson et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2008)
Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific affibody molecule
Vladimir Tolmachev et al.
CANCER RESEARCH (2007)
Optimization of electroporation-mediated transformation:: Staphylococcus carnosus as model organism
J. Lofblom et al.
JOURNAL OF APPLIED MICROBIOLOGY (2007)
Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor
M. Friedman et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2007)
Structural basis for molecular recognition in an Affibody:: Affibody complex
Christofer Lendel et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Tumor Imaging using a picomolar affinity HER2 binding affibody molecule
A Orlova et al.
CANCER RESEARCH (2006)
Fine affinity discrimination by normalized fluorescence activated cell sorting in staphylococcal surface display
J Löfblom et al.
FEMS MICROBIOLOGY LETTERS (2005)
Cetuximab: an IgG1 monoclonal antibody for the treatment of epidermal growth factor receptor-expressing tumours
Y Humblet
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Share Paper
